Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation
暂无分享,去创建一个
P. Cottu | M. Tanguy | C. Lemanski | A. Savignoni | Y. Kirova | C. Lévy | P. Bontemps | K. Peignaux | A. Reynaud-Bougnoux | B. de la Lande | A. Clément-Zhao | P. Baumann | A. Gobillion